Literature DB >> 23827221

Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease.

J J Rodríguez1, H N Noristani, T Hilditch, M Olabarria, C Y Yeh, J Witton, A Verkhratsky.   

Abstract

Alzheimer's disease (AD) is an irreversible neurodegenerative disease that is characterised by the presence of β-amyloid (Aβ) plaques, neurofibrillary tangles (NFTs) and synaptic loss specifically in brain regions involved in learning and memory such as the neocortex and the hippocampus. Aβ depositions in the form of neuritic plaques trigger activation of microglia that is believed to be a common neuropathological feature of AD brains. As an integral part of the hippocampus, the dentate gyrus (DG) plays an important role in cognitive function. Although post-mortem studies suggest later involvement of the DG into the AD progression, changes in microglia have not been studied in this subfield of the hippocampus. In the present study the numerical density (Nv, #/mm(3)) of both resting (identified by tomato lectin staining) and activated (identified by Mac-1 immunoreactivity) microglia was analysed in the molecular layer (ML) of the DG in the triple transgenic (3xTg-AD) mouse model of AD at different ages (9, 12 and 18 months). The 3xTg-AD mouse model of AD showed a significant increase in the Nv of resting (by 75%) and activated (by 67%) at 18 months of age compared to non-Tg controls. These results indicate a complex microglial remodelling during AD progression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Activated microglia; CA1 hippocampus; Dentate gyrus; Triple transgenic AD

Mesh:

Substances:

Year:  2013        PMID: 23827221     DOI: 10.1016/j.neulet.2013.06.036

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.

Authors:  Angélica Maria Sabogal-Guáqueta; Juan Ignacio Muñoz-Manco; Jose R Ramírez-Pineda; Marisol Lamprea-Rodriguez; Edison Osorio; Gloria Patricia Cardona-Gómez
Journal:  Neuropharmacology       Date:  2015-02-07       Impact factor: 5.250

2.  Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Malia M Edwards; José J Rodríguez; Raquel Gutierrez-Lanza; Joseph Yates; Alexei Verkhratsky; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2014-08-19       Impact factor: 3.467

Review 3.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

4.  Moderate Treadmill Exercise Protects Synaptic Plasticity of the Dentate Gyrus and Related Signaling Cascade in a Rat Model of Alzheimer's Disease.

Authors:  An T Dao; Munder A Zagaar; Karim A Alkadhi
Journal:  Mol Neurobiol       Date:  2014-10-08       Impact factor: 5.590

5.  Retina and Brain Display Early and Differential Molecular and Cellular Changes in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Ana Catarina Rodrigues-Neves; Rafael Carecho; Sónia Catarina Correia; Cristina Carvalho; Elisa Julião Campos; Filipa Isabel Baptista; Paula Isabel Moreira; António Francisco Ambrósio
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

6.  EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.

Authors:  Liang Peng; Vladimir Parpura; Alexei Verkhratsky
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

Review 7.  Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease.

Authors:  David Heras-Sandoval; José Pedraza-Chaverri; Jazmin M Pérez-Rojas
Journal:  J Neuroinflammation       Date:  2016-03-10       Impact factor: 8.322

8.  Role of Liver X Receptor in AD Pathophysiology.

Authors:  Adrián G Sandoval-Hernández; Luna Buitrago; Herman Moreno; Gloria Patricia Cardona-Gómez; Gonzalo Arboleda
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

9.  Increased Calcium-Sensing Receptor Immunoreactivity in the Hippocampus of a Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Emanuela Gardenal; Anna Chiarini; Ubaldo Armato; Ilaria Dal Prà; Alexei Verkhratsky; José J Rodríguez
Journal:  Front Neurosci       Date:  2017-02-16       Impact factor: 4.677

10.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.